546 related articles for article (PubMed ID: 10873770)
1. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
[TBL] [Abstract][Full Text] [Related]
2. The cowpox virus SPI-3 and myxoma virus SERP1 serpins are not functionally interchangeable despite their similar proteinase inhibition profiles in vitro.
Wang YX; Turner PC; Ness TL; Moon KB; Schoeb TR; Moyer RW
Virology; 2000 Jul; 272(2):281-92. PubMed ID: 10873771
[TBL] [Abstract][Full Text] [Related]
3. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
McGowen R; Biliran H; Sager R; Sheng S
Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
[TBL] [Abstract][Full Text] [Related]
4. Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases.
Wang Q; Shaltiel S
BMC Biochem; 2003 Jul; 4():5. PubMed ID: 12848892
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of plasmin, urokinase, tissue plasminogen activator, and C1S by a myxoma virus serine proteinase inhibitor.
Lomas DA; Evans DL; Upton C; McFadden G; Carrell RW
J Biol Chem; 1993 Jan; 268(1):516-21. PubMed ID: 8416956
[TBL] [Abstract][Full Text] [Related]
6. SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation.
Macen JL; Upton C; Nation N; McFadden G
Virology; 1993 Aug; 195(2):348-63. PubMed ID: 8337817
[TBL] [Abstract][Full Text] [Related]
7. The cowpox virus fusion regulator proteins SPI-3 and hemagglutinin interact in infected and uninfected cells.
Turner PC; Moyer RW
Virology; 2006 Mar; 347(1):88-99. PubMed ID: 16378629
[TBL] [Abstract][Full Text] [Related]
8. Rational design of complex formation between plasminogen activator inhibitor-1 and its target proteinases.
Aertgeerts K; De Ranter CJ; Booth NA; Declerck PJ
J Struct Biol; 1997 Apr; 118(3):236-42. PubMed ID: 9169233
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride.
Jankun J; Skrzypczak-Jankun E
Cancer Biochem Biophys; 1999 Jul; 17(1-2):109-23. PubMed ID: 10738907
[TBL] [Abstract][Full Text] [Related]
10. Orthopoxvirus fusion inhibitor glycoprotein SPI-3 (open reading frame K2L) contains motifs characteristic of serine proteinase inhibitors that are not required for control of cell fusion.
Turner PC; Moyer RW
J Virol; 1995 Oct; 69(10):5978-87. PubMed ID: 7666502
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the regulation of urokinase and tissue type plasminogen activators by the serpin, protein C inhibitor, in semen and blood plasma.
España F; Estellés A; Fernández PJ; Gilabert J; Sánchez-Cuenca J; Griffin JH
Thromb Haemost; 1993 Dec; 70(6):989-94. PubMed ID: 8165623
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory specificity of the anti-inflammatory myxoma virus serpin, SERP-1.
Nash P; Whitty A; Handwerker J; Macen J; McFadden G
J Biol Chem; 1998 Aug; 273(33):20982-91. PubMed ID: 9694848
[TBL] [Abstract][Full Text] [Related]
13. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
[TBL] [Abstract][Full Text] [Related]
14. An ester bond linking a fragment of a serine proteinase to its serpin inhibitor.
Egelund R; Rodenburg KW; Andreasen PA; Rasmussen MS; Guldberg RE; Petersen TE
Biochemistry; 1998 May; 37(18):6375-9. PubMed ID: 9572853
[TBL] [Abstract][Full Text] [Related]
15. Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop.
Gils A; Knockaert I; Declerck PJ
Biochemistry; 1996 Jun; 35(23):7474-81. PubMed ID: 8652525
[TBL] [Abstract][Full Text] [Related]
16. The axonally secreted serine proteinase inhibitor, neuroserpin, inhibits plasminogen activators and plasmin but not thrombin.
Osterwalder T; Cinelli P; Baici A; Pennella A; Krueger SR; Schrimpf SP; Meins M; Sonderegger P
J Biol Chem; 1998 Jan; 273(4):2312-21. PubMed ID: 9442076
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
Zhang X; Chaudhry A; Chintala SK
Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for serpin inhibitor activity.
Wright HT; Scarsdale JN
Proteins; 1995 Jul; 22(3):210-25. PubMed ID: 7479695
[TBL] [Abstract][Full Text] [Related]
19. Myxoma viral serpin, Serp-1, inhibits human monocyte adhesion through regulation of actin-binding protein filamin B.
Viswanathan K; Richardson J; Togonu-Bickersteth B; Dai E; Liu L; Vatsya P; Sun YM; Yu J; Munuswamy-Ramanujam G; Baker H; Lucas AR
J Leukoc Biol; 2009 Mar; 85(3):418-26. PubMed ID: 19052145
[TBL] [Abstract][Full Text] [Related]
20. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
